Literature DB >> 11870716

Localized bioimpedance analysis in the evaluation of neuromuscular disease.

Seward B Rutkove1, Ronald Aaron, Carl A Shiffman.   

Abstract

Localized bioimpedance analysis is a novel, noninvasive technique with potential application to neuromuscular disease. In this procedure, high-frequency alternating current is passed through muscle, and parameters related to the consequent voltage pattern are evaluated. Currents flowing perpendicular to muscle fibers encounter many more cell membranes than do currents flowing parallel to them, producing surface voltage patterns that are altered by disease. Using this technique, 45 normal subjects and 25 patients with various neuromuscular diseases were studied, including 4 with amyotrophic lateral sclerosis, 4 with inflammatory myopathy, and 11 with inclusion-body myositis. Two parameters, the spatially averaged phase and the effective longitudinal resistivity, were altered in patients with neuromuscular disease. Reductions in phase correlated to disease progression, whereas normalization of phase correlated with disease remission. In patients with inclusion-body myositis, a unique pattern of reduced phase and elevated resistivity was identified. These findings suggest that localized bioimpedance analysis has the potential of playing a substantial role in the diagnostic and therapeutic evaluation of neuromuscular disease. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11870716     DOI: 10.1002/mus.10048

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  49 in total

1.  Electrical impedance myography to assess outcome in amyotrophic lateral sclerosis clinical trials.

Authors:  Seward B Rutkove; Hui Zhang; David A Schoenfeld; Elizabeth M Raynor; Jeremy M Shefner; Merit E Cudkowicz; Anne B Chin; Ronald Aaron; Carl A Shiffman
Journal:  Clin Neurophysiol       Date:  2007-09-25       Impact factor: 3.708

2.  Optimizing measurement of the electrical anisotropy of muscle.

Authors:  Anne B Chin; Lindsay P Garmirian; Rui Nie; Seward B Rutkove
Journal:  Muscle Nerve       Date:  2008-05       Impact factor: 3.217

3.  A portable system for the assessment of neuromuscular diseases with electrical impedance myography.

Authors:  O T Ogunnika; S B Rutkove; H Ma; P M Fogerson; M Scharfstein; R C Cooper; J L Dawson
Journal:  J Med Eng Technol       Date:  2010-07-29

4.  Alteration in surface muscle electrical anisotropy in the rat SOD1 model of amyotrophic lateral sclerosis.

Authors:  Jia Li; Seward B Rutkove
Journal:  Clin Neurophysiol       Date:  2011-07-06       Impact factor: 3.708

5.  Utilizing a handheld electrode array for localized muscle impedance measurements.

Authors:  Pushpa Narayanaswami; Andrew J Spieker; Phillip Mongiovi; John C Keel; Stefan C Muzin; Seward B Rutkove
Journal:  Muscle Nerve       Date:  2012-08       Impact factor: 3.217

6.  Electrical impedance myography as a biomarker for ALS.

Authors:  Seward Rutkove
Journal:  Lancet Neurol       Date:  2009-03       Impact factor: 44.182

7.  Finite element analysis of electrical impedance myography in the rat hind limb.

Authors:  Mohammad A Ahad; Seward B Rutkove
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

8.  Discriminating neurogenic from myopathic disease via measurement of muscle anisotropy.

Authors:  Lindsay P Garmirian; Anne B Chin; Seward B Rutkove
Journal:  Muscle Nerve       Date:  2009-01       Impact factor: 3.217

9.  Electrical characteristics of rat skeletal muscle in immaturity, adulthood and after sciatic nerve injury, and their relation to muscle fiber size.

Authors:  Mohammad A Ahad; P Michelle Fogerson; Glenn D Rosen; Pushpa Narayanaswami; Seward B Rutkove
Journal:  Physiol Meas       Date:  2009-11-04       Impact factor: 2.833

10.  Optimizing electrode configuration for electrical impedance measurements of muscle via the finite element method.

Authors:  Mina Jafarpoor; Jia Li; Jacob K White; Seward B Rutkove
Journal:  IEEE Trans Biomed Eng       Date:  2013-01-09       Impact factor: 4.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.